Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.20.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Revenue:    
Total revenue $ 1,809,993 $ 2,457,871
Costs and expenses:    
Cost of products and services 1,197,061 1,280,270
Research and development 1,157,222 1,208,160
Selling and marketing 680,629 1,009,568
General and administrative 4,580,615 3,436,956
Total operating costs and expenses 7,615,527 6,934,954
Operating loss (5,805,534) (4,477,083)
Other (expense) income:    
Interest expense (5,281,480) (4,168,214)
Other income (expense) 4,018 (15,135)
(Loss) gain on extinguishment of liabilities (795,089) 260,454
Incentive shares and warrants (1,299,340)
Total other expense (6,072,551) (5,222,235)
Income tax benefit 217,168
Net loss (11,660,917) (9,699,318)
Deemed dividends on down round feature (213,012)
Deemed dividends on beneficial conversion feature (2,653,344) (12,881,899)
Preferred stock dividends (1,553,822) (678,921)
Net loss attributable to common shareholders $ (15,868,083) $ (23,473,150)
Net loss per share - basic and diluted $ (7.98) $ (15.33)
Weighted average common stock shares outstanding used in the basic and diluted net loss per share calculation 1,987,606 1,530,989
Products, Services, Other [Member]    
Revenue:    
Total revenue $ 1,809,993 $ 2,200,539
Grant Revenue [Member]    
Revenue:    
Total revenue $ 257,332